Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of antiretroviral prophylaxis on gene expression in the cervicovaginal tract and the blood

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE139655 | GEO | 2020/07/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of antiretroviral prophylaxis on gene expression in the cervicovaginal tract and the blood

Project description:Effect of antiretroviral prophylaxis on gene expression in the cervicovaginal tract and the blood

| PRJNA586827 | ENA

Effect of pre-exposure prophylaxis with tenofovir disoproxil fumarate and emtricitabine on gene expression

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-07-07 | GSE139611 | GEO

Clinical administration of chloroquine to HIV-infected patients that are untreated or receiving antiretroviral therapy

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-07-15 | E-GEOD-71065 | biostudies-arrayexpress

The effects of host-microbe interactions on cervicovaginal epithelial cells

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-12-14 | GSE234837 | GEO

Effect of antiretroviral prophylaxis on gene expression in peripheral blood mononuclear cells

Project description:It is important to understand how, if at all, antiretroviral prophylaxis with tenofovir disoproxil fumarate (TDF) alone or TDF in conjunction with emtricitabine (FTC) affects gene expression. To ask this question, we used cryopreserved peripheral blood mononuclear cells (PBMC) from women enrolled in the Genital Mucosal Substudy (GMS) [1] of the Partners PrEP Study (NCT02621242) [2]. Partners PrEP was a randomized Phase III trial of oral TDF or TDF/FTC compared to placebo, which showed that either active drug was effective at protecting against HIV-1 infection. Samples were unpaired, with one sample per person, after 24-36 months of oral treatment with placebo, TDF, or TDF/FTC. Treatment adherence was based on plasma TDF concentrations. Covariates included Nugent scores (for bacterial vaginosis), HSV-2 serology, age, and birth control method. Levels of natural and synthetic hormones (medroxyprogesterone acetate [MPA], estradiol [E2], ethinyl estradiol [EE2], levonorgestrel [LNG], etonogestrel [ENG], progesterone [P4], and norethisterone enanthate [NET-EN]) were measured in the serum. 1. Lund, J. M. et al. HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis. J. Virol. 90, 9855–9861 (2016). 2. Baeten, J. M. et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N. Engl. J. Med. 367, 399–410 (2012).

2020-07-07 | GSE139411 | GEO

Effect of PCO1 overexpression

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-02-07 | E-GEOD-44344 | biostudies-arrayexpress

Chromatin state dynamics during blood formation

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-08-08 | E-GEOD-60103 | biostudies-arrayexpress

BBBomics - Human Blood Brain Barrier Transcriptomics Hub

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-03-17 | E-GEOD-76531 | biostudies-arrayexpress

TALE transcription factors binding and transcriptional effect

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series